Literature DB >> 27532511

Trends in Type of Original Psoriasis Publications by Decade, 1960 to 2010.

Eric Sako1, Shannon Famenini2, Jashin J Wu3.   

Abstract

CONTEXT: Research investigating psoriasis has spanned decades, and as our understanding of the disease has evolved, the focus of publications has changed.
OBJECTIVE: We sought to characterize the trends in original psoriasis-related research from 1960 to 2010 chronologically by decade.
METHODS: A literature review was performed using the keyword psoriasis in the MEDLINE database. All original psoriasis-related articles published at the beginning of each decade were searched and categorized by study type and topic. MAIN OUTCOME MEASURE: Number of articles per topic.
RESULTS: A total of 869 original psoriasis-related articles were found. The number of publications increased 18 fold over 5 decades. The immunology and pathogenesis of psoriasis was the most frequently researched topic (36%), and retrospective studies were the most common study type (37%). Recent highly published topics included biologic therapy, genetics, and psoriasis-associated cardiovascular disease.
CONCLUSION: Original psoriasis-related publications have grown substantially since 1960. Basic science research into the immunology and pathogenesis has been and continues to be the mainstay of psoriasis research. Recent research trends suggest the focus has expanded to topics such as psoriasis-associated cardiovascular disease, genetics, and biologic therapy.

Entities:  

Mesh:

Year:  2016        PMID: 27532511      PMCID: PMC5101079          DOI: 10.7812/TPP/15-060

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  18 in total

1.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Authors:  U Chaudhari; P Romano; L D Mulcahy; L T Dooley; D G Baker; A B Gottlieb
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

2.  Cyclosporin A for psoriasis.

Authors:  W Mueller; B Herrmann
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

3.  High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients.

Authors:  P Ena; P Madeddu; N Glorioso; D Cerimele; A Rappelli
Journal:  Acta Cardiol       Date:  1985       Impact factor: 1.718

4.  Cyclosporine improves psoriasis in a double-blind study.

Authors:  C N Ellis; D C Gorsulowsky; T A Hamilton; J K Billings; M D Brown; J T Headington; K D Cooper; O Baadsgaard; E A Duell; T M Annesley
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

5.  Methotrexate for psoriasis.

Authors:  R B Rees; J H Bennett; H I Maibach; H L Arnold
Journal:  Arch Dermatol       Date:  1967-01

6.  The risk of stroke in patients with psoriasis.

Authors:  Joel M Gelfand; Erica D Dommasch; Daniel B Shin; Rahat S Azfar; Shanu K Kurd; Xingmei Wang; Andrea B Troxel
Journal:  J Invest Dermatol       Date:  2009-05-21       Impact factor: 8.551

Review 7.  Three decades of psoriasis research: where has it led us?

Authors:  Robert Sabat; Wolfram Sterry; Sandra Philipp; Kerstin Wolk
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

8.  Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.

Authors:  Jashin J Wu; Kwun-Yee T Poon; Jennifer C Channual; Albert Yuh-Jer Shen
Journal:  Arch Dermatol       Date:  2012-11

9.  Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab.

Authors:  Rudolf E Schopf; Holger Aust; Jürgen Knop
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527

Review 10.  Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.

Authors:  Eleanor J Samarasekera; Julie M Neilson; Richard B Warren; Jill Parnham; Catherine H Smith
Journal:  J Invest Dermatol       Date:  2013-02-21       Impact factor: 8.551

View more
  1 in total

1.  The Depigmented Literature: A Holistic Analysis of Global Vitiligo Publications between 1975 and 2017.

Authors:  Engin Şenel
Journal:  Indian J Dermatol       Date:  2020 Sep-Oct       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.